Hypermarcas Total Assets 2012-2025 | HYPMY

Hypermarcas total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Hypermarcas Annual Total Assets
(Millions of US $)
2024 $4,553
2023 $4,909
2022 $4,601
2021 $3,672
2020 $3,346
2019 $3,020
2018 $2,888
2017 $3,173
2016 $3,293
2015 $4,831
2014 $5,934
2013 $5,827
2012 $6,516
2011 $8,008
Hypermarcas Quarterly Total Assets
(Millions of US $)
2025-09-30 $4,618
2025-06-30 $4,278
2025-03-31 $4,153
2024-12-31 $4,553
2024-09-30 $4,665
2024-06-30 $4,861
2024-03-31 $5,103
2023-12-31 $4,909
2023-09-30 $4,971
2023-06-30 $4,810
2023-03-31 $4,335
2022-12-31 $4,601
2022-09-30 $4,302
2022-06-30 $4,250
2022-03-31 $3,899
2021-12-31 $3,672
2021-09-30 $3,838
2021-06-30 $3,503
2021-03-31 $3,288
2020-12-31 $3,346
2020-09-30 $3,177
2020-06-30 $2,917
2020-03-31 $2,734
2019-12-31 $3,020
2019-09-30 $2,736
2019-06-30 $2,686
2019-03-31 $2,742
2018-12-31 $2,888
2018-09-30 $2,603
2018-06-30 $2,751
2018-03-31 $2,985
2017-12-31 $3,173
2017-09-30 $3,140
2017-06-30 $3,267
2017-03-31 $3,386
2016-12-31 $3,293
2016-09-30 $3,842
2016-06-30 $3,720
2016-03-31 $3,422
2015-12-31 $4,831
2015-09-30 $4,238
2015-06-30 $5,032
2015-03-31 $4,642
2014-12-31 $5,934
2014-09-30 $6,003
2014-06-30 $5,892
2014-03-31 $5,444
2013-12-31 $5,827
2013-09-30 $5,825
2013-06-30 $6,225
2013-03-31 $6,344
2012-12-31 $6,516
2012-09-30 $6,380
2012-06-30 $6,780
2012-03-31 $7,393
2011-12-31 $8,008
2011-09-30 $8,385
2011-06-30 $8,608
2011-03-31 $7,833
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.755B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.346B 32.25
Takeda Pharmaceutical (TAK) Japan $56.926B 11.18
Zoetis (ZTS) United States $56.153B 20.10
BeOne Medicines - (ONC) Switzerland $38.812B 205.77
Sandoz Group AG (SDZNY) Switzerland $35.065B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.401B 0.00
United Therapeutics (UTHR) United States $20.898B 18.39
Merck (MKKGY) Germany $18.714B 11.54
Shionogi (SGIOY) Japan $18.571B 14.36
Neurocrine Biosciences (NBIX) United States $14.078B 33.78
Ionis Pharmaceuticals (IONS) United States $14.011B 0.00
IPSEN (IPSEY) France $13.491B 0.00
Summit Therapeutics (SMMT) United States $11.560B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) United States $10.847B 0.00
Eisai (ESAIY) $8.574B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.149B 17.10
Stevanato Group S.p.A (STVN) Italy $4.694B 26.27
Crinetics Pharmaceuticals (CRNX) United States $4.626B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.591B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.565B 21.67
Indivior Pharmaceuticals (INDV) United States $4.296B 17.53
Corcept Therapeutics (CORT) United States $4.295B 46.40
NewAmsterdam Pharma (NAMS) Netherlands $3.889B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.158B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.004B 9.58
Dyne Therapeutics (DYN) United States $2.399B 0.00
Soleno Therapeutics (SLNO) United States $2.231B 0.00
Guardian Pharmacy Services (GRDN) United States $2.145B 41.32
Avadel Pharmaceuticals (AVDL) Ireland $2.118B 0.00
Ocular Therapeutix (OCUL) United States $1.994B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.904B 22.56
Ardelyx (ARDX) United States $1.779B 0.00
Harrow (HROW) United States $1.753B 107.54
Enliven Therapeutics (ELVN) United States $1.746B 0.00
Definium Therapeutics (DFTX) United States $1.665B 0.00
Oruka Therapeutics (ORKA) United States $1.600B 0.00
Relay Therapeutics (RLAY) United States $1.546B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.535B 0.00
Collegium Pharmaceutical (COLL) United States $1.505B 7.45
BioCryst Pharmaceuticals (BCRX) United States $1.345B 79.75
Evotec AG (EVO) Germany $1.254B 0.00
Xeris Biopharma Holdings (XERS) United States $1.163B 0.00
Savara (SVRA) United States $1.078B 0.00
Theravance Biopharma (TBPH) United States $1.038B 43.57
Cronos Group (CRON) Canada $1.004B 0.00
ARS Pharmaceuticals (SPRY) United States $0.991B 0.00
Aktis Oncology (AKTS) United States $0.961B 0.00
Xencor (XNCR) United States $0.829B 0.00
Esperion Therapeutics (ESPR) United States $0.813B 0.00
KalVista Pharmaceuticals (KALV) United States $0.753B 0.00
Nektar Therapeutics (NKTR) United States $0.749B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.742B 17.54
Bioventus (BVS) United States $0.704B 14.42
Rigel Pharmaceuticals (RIGL) United States $0.620B 5.53
ProKidney (PROK) United States $0.563B 0.00
Altimmune (ALT) United States $0.550B 0.00
Lexeo Therapeutics (LXEO) United States $0.523B 0.00
4D Molecular Therapeutics (FDMT) United States $0.514B 0.00
Aquestive Therapeutics (AQST) United States $0.501B 0.00
Zevra Therapeutics (ZVRA) United States $0.484B 0.00
Lyell Immunopharma (LYEL) United States $0.482B 0.00
Elite Pharmaceuticals (ELTP) United States $0.481B 0.00
Siga Technologies (SIGA) United States $0.480B 6.57
Organogenesis (ORGO) United States $0.478B 0.00
Nature's Sunshine Products (NATR) United States $0.461B 27.43
USANA Health Sciences (USNA) United States $0.390B 10.89
Aclaris Therapeutics (ACRS) United States $0.387B 0.00
Akebia Therapeutics (AKBA) United States $0.369B 0.00
Protara Therapeutics (TARA) United States $0.343B 0.00
Aldeyra Therapeutics (ALDX) United States $0.333B 0.00
Cybin (HELP) Canada $0.298B 0.00
Relmada Therapeutics (RLMD) United States $0.285B 0.00
Larimar Therapeutics (LRMR) United States $0.279B 0.00
Journey Medical (DERM) United States $0.278B 0.00
Enlivex Therapeutics (ENLV) Israel $0.275B 0.00
Avalo Therapeutics (AVTX) United States $0.263B 0.00
OmniAb (OABI) United States $0.245B 0.00
Profound Medical (PROF) Canada $0.236B 0.00
Heron Therapeutics (HRTX) United States $0.231B 0.00
MediWound (MDWD) Israel $0.228B 0.00
Achieve Life Sciences (ACHV) Canada $0.226B 0.00
Silence Therapeutics (SLN) United Kingdom $0.224B 0.00
Context Therapeutics (CNTX) United States $0.209B 0.00
Minerva Neurosciences (NERV) United States $0.208B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Surrozen (SRZN) United States $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.181B 0.00
AleAnna (ANNA) United States $0.179B 0.00
Century Therapeutics (IPSC) United States $0.149B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Unicycive Therapeutics (UNCY) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.137B 0.00
Prelude Therapeutics (PRLD) United States $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.128B 0.00
Avita Medical (RCEL) United States $0.119B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Karyopharm Therapeutics (KPTI) United States $0.115B 0.00
Cardiol Therapeutics (CRDL) Canada $0.111B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.110B 0.00
Incannex Healthcare (IXHL) Australia $0.100B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Cassava Sciences (SAVA) United States $0.098B 0.00
Pyxis Oncology (PYXS) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.091B 38.53
Assertio Holdings (ASRT) United States $0.082B 0.00
PolyPid (PYPD) Israel $0.072B 0.00
HST Global (HSTC) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Dominari Holdings (DOMH) United States $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.88
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
BioNxt Solutions (BNXTF) Canada $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.055B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Acrivon Therapeutics (ACRV) United States $0.053B 0.00
Liminatus Pharma (LIMN) United States $0.050B 0.00
Lipocine (LPCN) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
Wellgistics Health (WGRX) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
TherapeuticsMD (TXMD) United States $0.027B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Klotho Neurosciences (KLTO) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.02
Vyome Holdings (HIND) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
Inotiv (NOTV) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.003B 0.00
Ernexa Therapeutics (ERNA) United States $0.003B 0.00
China SXT Pharmaceuticals (SXTC) China $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00